Encompass Health Corporation $EHC Position Lifted by Creative Planning

Creative Planning raised its stake in Encompass Health Corporation (NYSE:EHC) by 14.9% in the 2nd quarter, Holdings Channel.com reports. The firm owned 28,328 shares of the company’s stock after acquiring an additional 3,681 shares during the period. Creative Planning’s holdings in Encompass Health were worth $3,474,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of EHC. WPG Advisers LLC bought a new stake in Encompass Health in the first quarter valued at about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in shares of Encompass Health by 749.0% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock worth $42,000 after acquiring an additional 367 shares in the last quarter. Parkside Financial Bank & Trust increased its holdings in shares of Encompass Health by 179.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock valued at $59,000 after acquiring an additional 307 shares during the last quarter. Park Place Capital Corp acquired a new stake in shares of Encompass Health during the 2nd quarter valued at approximately $72,000. Finally, Caitong International Asset Management Co. Ltd lifted its stake in Encompass Health by 19.0% during the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after purchasing an additional 115 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Insider Buying and Selling at Encompass Health

In related news, EVP Patrick William Tuer sold 1,020 shares of the company’s stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the sale, the executive vice president owned 18,846 shares of the company’s stock, valued at $2,329,177.14. This represents a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have weighed in on EHC shares. KeyCorp boosted their target price on shares of Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Tuesday, September 16th. Bank of America boosted their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, September 10th. Zacks Research lowered shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday. Finally, Raymond James Financial upgraded Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Two research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $142.86.

Encompass Health Price Performance

NYSE EHC opened at $114.44 on Friday. The company has a 50-day moving average price of $121.34 and a two-hundred day moving average price of $119.56. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $127.99. The stock has a market cap of $11.51 billion, a price-to-earnings ratio of 21.63, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%.The business had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is 14.37%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.